The 7 analysts offering 12-month price forecasts for Replimune Group Inc have a median target of 30.00, with a high estimate of 40.00 and a low estimate of 25.00. The median estimate represents a +26.96% increase from the last price of 23.63.
The current consensus among 7 polled investment analysts is to Buy stock in Replimune Group Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.43
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.